199 related articles for article (PubMed ID: 29508130)
41. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
42. Human herpesvirus 8/Kaposi sarcoma herpesvirus cell association during evolution of Kaposi sarcoma.
Pyakurel P; Massambu C; Castaños-Vélez E; Ericsson S; Kaaya E; Biberfeld P; Heiden T
J Acquir Immune Defic Syndr; 2004 Jun; 36(2):678-83. PubMed ID: 15167286
[TBL] [Abstract][Full Text] [Related]
43. [Clinical studies and treatment of Karposi's sarcoma of the head and neck in AIDS patients].
Bujía J; Riederer A; Zietz C; Vogl T; Wilmes E
An Otorrinolaringol Ibero Am; 1993; 20(3):267-77. PubMed ID: 8317635
[TBL] [Abstract][Full Text] [Related]
44. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
Daly ML; Fogo A; McDonald C; Morris-Jones R
Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
[TBL] [Abstract][Full Text] [Related]
45. Oropharyngeal kaposi sarcoma in related persons negative for human immunodeficiency virus.
Sikora AG; Shnayder Y; Yee H; DeLacure MD
Ann Otol Rhinol Laryngol; 2008 Mar; 117(3):172-6. PubMed ID: 18444476
[TBL] [Abstract][Full Text] [Related]
46. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda.
Okuku F; Krantz EM; Kafeero J; Kamya MR; Orem J; Casper C; Phipps W
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):548-554. PubMed ID: 28107226
[TBL] [Abstract][Full Text] [Related]
48. Kaposi's sarcoma of the head and neck in the acquired immune deficiency syndrome.
Patow CA; Steis R; Longo DL; Reichert CM; Findlay PA; Potter D; Masur H; Lane HC; Fauci AS; Macher AM
Otolaryngol Head Neck Surg; 1984 Jun; 92(3):255-60. PubMed ID: 6431361
[TBL] [Abstract][Full Text] [Related]
49. Pattern of head and neck malignant neoplasms in HIV-infected patients in Kenya.
Butt FM; Chindia ML; Rana F; Machigo FG
Int J Oral Maxillofac Surg; 2008 Oct; 37(10):907-11. PubMed ID: 18783921
[TBL] [Abstract][Full Text] [Related]
50. [Clinical manifestation of Kaposi sarcoma in otorhinolaryngology head and neck surgery].
Yu DX; Pi SJ; Zhang WS
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Mar; 48(3):241-3. PubMed ID: 23755792
[TBL] [Abstract][Full Text] [Related]
51. Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction.
Bobroski L; Bagasra AU; Patel D; Saikumari P; Memoli M; Abbey MV; Wood C; Sosa C; Bagasra O
J Reprod Immunol; 1998 Dec; 41(1-2):149-60. PubMed ID: 10213307
[TBL] [Abstract][Full Text] [Related]
52. Human herpesvirus 8 in Kaposi's sarcoma and Kaposi's sarcoma-mimicking vascular tumors.
Kang GH; Kwon GY; Kim CW
J Korean Med Sci; 1998 Feb; 13(1):54-9. PubMed ID: 9539320
[TBL] [Abstract][Full Text] [Related]
53. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells.
Stürzl M; Hohenadl C; Zietz C; Castanos-Velez E; Wunderlich A; Ascherl G; Biberfeld P; Monini P; Browning PJ; Ensoli B
J Natl Cancer Inst; 1999 Oct; 91(20):1725-33. PubMed ID: 10528022
[TBL] [Abstract][Full Text] [Related]
54. Radiation therapy in the treatment of HIV-related Kaposi's sarcoma.
Donato V; Guarnaccia R; Dognini J; de Pascalis G; Caruso C; Bellagamba R; Morrone A
Anticancer Res; 2013 May; 33(5):2153-7. PubMed ID: 23645769
[TBL] [Abstract][Full Text] [Related]
55. Evidence for a multiclonal origin of multicentric advanced lesions of Kaposi sarcoma.
Duprez R; Lacoste V; Brière J; Couppié P; Frances C; Sainte-Marie D; Kassa-Kelembho E; Lando MJ; Essame Oyono JL; Nkegoum B; Hbid O; Mahé A; Lebbé C; Tortevoye P; Huerre M; Gessain A
J Natl Cancer Inst; 2007 Jul; 99(14):1086-94. PubMed ID: 17623796
[TBL] [Abstract][Full Text] [Related]
56. Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis.
Openshaw MR; Gervasi E; Fulgenzi CAM; Pinato DJ; Dalla Pria A; Bower M
J Transl Med; 2023 Apr; 21(1):283. PubMed ID: 37106396
[TBL] [Abstract][Full Text] [Related]
57. Diagnostic challenges of oral and cutaneous Kaposi's sarcoma in resource-constrained settings.
Speicher DJ; Wanzala P; D'Lima M; Njiru A; Chindia M; Dimba E; Johnson NW
J Oral Pathol Med; 2015 Nov; 44(10):842-9. PubMed ID: 25782476
[TBL] [Abstract][Full Text] [Related]
58. [Update on Kaposi's sarcoma].
Morand JJ; Lightburn E; Simon F; Patte JH
Med Trop (Mars); 2007 Apr; 67(2):123-30. PubMed ID: 17691428
[TBL] [Abstract][Full Text] [Related]
59. Decreased immunoreactivity for cell-cycle regulator p27(Kip1) in Kaposi's sarcoma correlates with higher stage and extracutaneous involvement.
Fernández-Figueras MT; Puig L; Penín RM; Mate JL; Bigatà X; Ariza A
J Pathol; 2000 Aug; 191(4):387-93. PubMed ID: 10918213
[TBL] [Abstract][Full Text] [Related]
60. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
